Precipio Basic Shares Outstanding 2010-2024 | PRPO
Precipio basic shares outstanding from 2010 to 2024. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
| Precipio Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $1 |
| 2023 | $1 |
| 2022 | $1 |
| 2021 | $1 |
| 2020 | $1 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $49 |
| 2009 | $49 |
| Precipio Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1 |
| 2024-09-30 | $1 |
| 2024-06-30 | $1 |
| 2024-03-31 | $1 |
| 2023-12-31 | $1 |
| 2023-09-30 | $1 |
| 2023-06-30 | $1 |
| 2023-03-31 | $1 |
| 2022-12-31 | $1 |
| 2022-09-30 | $1 |
| 2022-06-30 | $1 |
| 2022-03-31 | $1 |
| 2021-12-31 | $1 |
| 2021-09-30 | $1 |
| 2021-06-30 | $1 |
| 2021-03-31 | $1 |
| 2020-12-31 | $1 |
| 2020-09-30 | $1 |
| 2020-06-30 | $1 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $72 |
| 2012-06-30 | $72 |
| 2012-03-31 | $63 |
| 2011-12-31 | $0 |
| 2011-09-30 | $49 |
| 2011-06-30 | $49 |
| 2011-03-31 | $49 |
| 2010-12-31 | $49 |
| 2010-09-30 | $49 |
| 2010-06-30 | $49 |
| 2010-03-31 | $49 |
| 2009-12-31 | $49 |
| 2009-09-30 | $49 |
| 2009-06-30 | $49 |
| 2009-03-31 | $49 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.010B | $0.019B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||